NCT04806269 is a clinical trial of Fitbit and Glandy in Thyrotoxicosis, sponsored by Seoul National University Bundang Hospital.

Who is sponsoring NCT04806269?

NCT04806269 is sponsored by Seoul National University Bundang Hospital.

What drugs are being tested in NCT04806269?

Interventions in NCT04806269: Fitbit and Glandy.

What condition does NCT04806269 study?

NCT04806269 studies Thyrotoxicosis, Hypothyroidism.

Is NCT04806269 still recruiting?

NCT04806269 is currently status unknown. Last updated 13 April 2023.

Last reviewed 2023-04-13 · How we verify

NCT04806269

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biosignals by Wearables in Thyroid Dysfunction

Status unknown Last updated 13 April 2023

What this trial tests

trial testing Fitbit and Glandy in Thyrotoxicosis in 120 participants. Status unknown.

Timeline

18 January 2021

Primary endpoint
30 September 2023

31 December 2023

Quick facts

Lead sponsor	Seoul National University Bundang Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	120
Start date	18 January 2021
Primary completion	30 September 2023
Estimated completion	31 December 2023
Sites	1 location across South Korea

Drugs / interventions tested

Fitbit and Glandy

Conditions studied

Thyrotoxicosis — all drugs for Thyrotoxicosis →
Hypothyroidism — all drugs for Hypothyroidism →

Sponsor

Seoul National University Bundang Hospital

Who can join

Adults 18 to 60, any sex, with Thyrotoxicosis or Hypothyroidism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single center observational study to investigate the association between biosignals from wearables and thyroid dysfunction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A machine learning-assisted system to predict thyrotoxicosis using patients' heart rate monitoring data: a retrospective cohort study.
Shin K, Kim J, Park J, Oh TJ, et al · · 2023 · cited 2× · PMID 38036639 · DOI 10.1038/s41598-023-48199-x

Verify or expand the search:

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04806269 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
Last refreshed: 13 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04806269.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing